MARX Biotech Statistics

Total Valuation

MARX Biotech has a market cap or net worth of TWD 3.00 billion. The enterprise value is 3.20 billion.

Market Cap	3.00B
Enterprise Value	3.20B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

MARX Biotech has 498.06 million shares outstanding. The number of shares has increased by 17.36% in one year.

Current Share Class	n/a
Shares Outstanding	498.06M
Shares Change (YoY)	+17.36%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	23.56%
Owned by Institutions (%)	n/a
Float	301.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.86
PB Ratio	11.95
P/TBV Ratio	18.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-33.07
EV / Sales	5.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.17

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.10.

Current Ratio	1.32
Quick Ratio	0.66
Debt / Equity	1.10
Debt / EBITDA	n/a
Debt / FCF	-0.88
Interest Coverage	-38.46

Financial Efficiency

Return on equity (ROE) is -35.58% and return on invested capital (ROIC) is -12.90%.

Return on Equity (ROE)	-35.58%
Return on Assets (ROA)	-9.44%
Return on Invested Capital (ROIC)	-12.90%
Return on Capital Employed (ROCE)	-20.11%
Revenue Per Employee	7.73M
Profits Per Employee	-1.21M
Employee Count	80
Asset Turnover	1.10
Inventory Turnover	1.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.86%
50-Day Moving Average	7.10
200-Day Moving Average	8.22
Relative Strength Index (RSI)	35.53
Average Volume (20 Days)	654,093

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MARX Biotech had revenue of TWD 618.23 million and -96.83 million in losses. Loss per share was -0.19.

Revenue	618.23M
Gross Profit	430.07M
Operating Income	-85.00M
Pretax Income	-97.43M
Net Income	-96.83M
EBITDA	-67.36M
EBIT	-85.00M
Loss Per Share	-0.19

Full Income Statement

Balance Sheet

The company has 78.17 million in cash and 277.32 million in debt, giving a net cash position of -199.15 million or -0.40 per share.

Cash & Cash Equivalents	78.17M
Total Debt	277.32M
Net Cash	-199.15M
Net Cash Per Share	-0.40
Equity (Book Value)	251.25M
Book Value Per Share	0.50
Working Capital	98.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -108.87 million and capital expenditures -206.00 million, giving a free cash flow of -314.87 million.

Operating Cash Flow	-108.87M
Capital Expenditures	-206.00M
Free Cash Flow	-314.87M
FCF Per Share	-0.63

Full Cash Flow Statement

Margins

Gross margin is 69.56%, with operating and profit margins of -13.75% and -15.66%.

Gross Margin	69.56%
Operating Margin	-13.75%
Pretax Margin	-15.76%
Profit Margin	-15.66%
EBITDA Margin	-10.90%
EBIT Margin	-13.75%
FCF Margin	n/a

Dividends & Yields

MARX Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.36%
Shareholder Yield	-17.36%
Earnings Yield	-3.22%
FCF Yield	-10.48%

Stock Splits

The last stock split was on July 11, 2024. It was a forward split with a ratio of 2.

Last Split Date	Jul 11, 2024
Split Type	Forward
Split Ratio	2

Scores

MARX Biotech has an Altman Z-Score of 5.21.

Altman Z-Score	5.21
Piotroski F-Score	n/a